After multiple trips to her GP and hospital Claire underwent a biopsy on the 7cm mass that revealed it was a stage four cutaneous malignant melanoma ...
Bio-Convert ApS, a Denmark-based clinical-stage biopharmaceutical company, is aiming to revolutionize the treatment of oral leukoplakia, by minimizing or removing oral leukoplakia lesions, that ...
Leveraging liquid nitrogen to target benign and malignant lesions, the ProSense system is said to offer a less invasive approach to killing tumours. Nine panellists voted in favour, noting that the ...
Sallman is myeloid section head and associate member of the Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. This article provides a thorough ...